Histiocytes, represent the cells of the mononuclear phagocyte system (MPS) that can give rise to histiocytoses when they accumulate pathogenically in tissues due to dysregulation of proliferation or ...

The cells seen on the fine-needle aspiration sample were consistent with a histiocytic origin. The gross appearance of the lesion along with the marked cellular homogeneity of the fine-needle ...

Flat-coated retrievers have a higher risk of getting soft tissue sarcoma — specifically histiocytic sarcoma — which is a rare ...

Histiocytic Malignancies, Neonatal Marfan Syndrome, PACS1 Syndrome, Plasmablastic Lymphoma, Renal Medullary Carcinoma, and ...

Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

A 57-year-old woman with no known comorbidities presented to our dermatology clinic with a 6-month history of asymptomatic lesions on her upper back and upper limbs. Examination revealed well-defined, ...

Detailed results from the TROPION-Lung01 Phase III trial showed a clinically meaningful trend toward improving overall survival (OS) with datopotamab ...

AtLP are conditions in which it is not possible to differentiate between the benign and the malignant nature of a given lymphoid infiltrate. The descriptive term AtLP may be used as an interim ...

A 50-year-old man was diagnosed with leprosy on pre-immigration screening in the Philippines and was prescribed oral dapsone and rifampin. He immigrated to Canada 1 month later and discontinued ...

Ensartinib hydrochloride is under clinical development by Betta Pharmaceuticals and currently in Phase II for Sarcomas.

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...

The histiocytoses are a group of rare disorders that involve an abnormal accumulation of a specific cell type (the histiocyte) in various organs. Histiocytes are mainly derived from the bone marrow, ...